 Receptors, Lysophosphatidic Acid
"Receptors, Lysophosphatidic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subfamily of lysophospholipid receptors with specificity for LYSOPHOSPHATIDIC ACIDS.
| Descriptor ID |
D049368
|
| MeSH Number(s) |
D12.776.543.750.695.420.249
|
| Concept/Terms |
Receptors, Lysophosphatidic Acid- Receptors, Lysophosphatidic Acid
- Acid Receptors, Lysophosphatidic
- Lysophosphatidic Acid Receptors
- Lysophosphatidic Acid Receptor
- Acid Receptor, Lysophosphatidic
- LPA Receptors
- Receptors, LPA
- Receptor, Lysophosphatidic Acid
LPA2 Receptor- LPA2 Receptor
- Receptor, LPA2
- Edg-4 Receptor
- Edg 4 Receptor
- Receptor, Edg-4
- Edg4 Protein
LPA3 Receptor- LPA3 Receptor
- Receptor, LPA3
- Edg-7 Receptor
- Edg 7 Receptor
- Receptor, Edg-7
- EDG7 Protein
LPA1 Receptor- LPA1 Receptor
- Receptor, LPA1
- vzg-1 Receptor
- Receptor, vzg-1
- vzg 1 Receptor
- LPA-1 Receptor
- LPA 1 Receptor
- Edg2 Protein
- edg-2 Receptor
- Receptor, edg-2
- edg 2 Receptor
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Lysophosphatidic Acid".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Lysophosphatidic Acid".
This graph shows the total number of publications written about "Receptors, Lysophosphatidic Acid" by people in this website by year, and whether "Receptors, Lysophosphatidic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 1 | 1 | | 2014 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Lysophosphatidic Acid" by people in Profiles.
-
Mathew D, Torres RM. Lysophosphatidic Acid Is an Inflammatory Lipid Exploited by Cancers for Immune Evasion via Mechanisms Similar and Distinct From CTLA-4 and PD-1. Front Immunol. 2020; 11:531910.
-
Kim GHJ, Goldin JG, Hayes W, Oh A, Soule B, Du S. The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis. Ther Adv Respir Dis. 2021 Jan-Dec; 15:17534666211004238.
-
Mathew D, Kremer KN, Strauch P, Tigyi G, Pelanda R, Torres RM. LPA5 Is an Inhibitory Receptor That Suppresses CD8 T-Cell Cytotoxic Function via Disruption of Early TCR Signaling. Front Immunol. 2019; 10:1159.
-
Hu J, Oda SK, Shotts K, Donovan EE, Strauch P, Pujanauski LM, Victorino F, Al-Shami A, Fujiwara Y, Tigyi G, Oravecz T, Pelanda R, Torres RM. Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response. J Immunol. 2014 Jul 01; 193(1):85-95.
-
Oda SK, Strauch P, Fujiwara Y, Al-Shami A, Oravecz T, Tigyi G, Pelanda R, Torres RM. Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression. Cancer Immunol Res. 2013 Oct; 1(4):245-55.
-
Li Y, Gonzalez MI, Meinkoth JL, Field J, Kazanietz MG, Tennekoon GI. Lysophosphatidic acid promotes survival and differentiation of rat Schwann cells. J Biol Chem. 2003 Mar 14; 278(11):9585-91.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|